i-Lens
Wockhardt Ltd Share Price
SECTOR : Pharmaceuticals | BSE :532300 | NSE : WOCKPHARMA
May 24, 2022 04:01 PM
| Date | Action Type | Ratio |
|---|---|---|
| No data found |
Wockhardt Ltd is in the Pharmaceuticals sector with the Market Capitalization of worth Rs. 5,314.72 crores, it is incorporated in the 1960s. It has reported consolidated sales of Rs. 764.02 crores in December’2020. The company is also listed in the Bombay Stock Exchange (BSE) with the code 532300 and listed in the National Stock Exchange (NSE) with the code WOCKPHARMA.
Wockhardt is a global biotechnology and pharmaceuticals company with its headquarters based in Mumbai. Wockhardt is engaged in producing biopharmaceuticals, nutrition products, vaccines, formulations, and active pharmaceuticals ingredients (APIs). The company has various manufacturing plants in India and the USA. Notably, more than half of its revenue is generated in Europe. It has a market presence in many countries around the globe, such as India, the USA, UK, Brazil, Russia, Mexico, Kenya, Ghana, etc. Wockhardt Hospitals, a subsidiary of Wockhardt ltd is a healthcare network of tertiary care and super specialty healthcare services in India. These hospitals offer services in the fields of Cardiology, Orthopedics, Neurology, Gastroenterology, Urology, etc. The promoters of the company own 69.68% of the stake in the company, Foreign Institutional Investors (FII) own 2.73%, Domestic Institutional Investors (DII) own 0.09% of the stake, and others (such as public & retail investors) hold the balance of 27.50%.
In June 2021, quarterly net revenue was Rs. 278.95 crores, which has increased by approximately 57.08 % from Rs. 177.58 crores for the April-June 2020 quarter. The quarterly net loss in June 2021 was Rs. 48.69 crores, which has seen a sharp decline by nearly 106.35% from a net profit of Rs. 766.39 crores in June 2020. In June 2021, the reported operating profit was at Rs. 199.96 crores, which is also reduced by 78.15% as compared to an operating profit of Rs. 915.08 crores for the quarter ending in June 2020. From Rs. 69.21 in June 2020, the EPS of Wockhardt Ltd has decreased to (Rs. 4.40) per share in June 2021. WOCKPHARMA’s stock closed at Rs. 488.50 on 17th August’2021 (NSE) and has returned -2.36% in the last six months and 49.78% in the previous year.
| AGM Date (Month) | : | Aug |
| Face Value Equity Shares | : | 5 |
| Market Lot Equity Shares | : | 1 |
| BSE Code | : | 532300 |
| NSE Code | : | WOCKPHARMA |
| Book Closure Date (Month) | : | Jul/Aug |
| BSE Group | : | A |
| ISIN | : | INE049B01025 |
